Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 6591981

Recent progress in improving data processing in filtration measurements.

P Teitel·H Malotta·M Leschke·H Schmid-Schönbein
View original source ↗Export metadata ↓

Abstract

Nucleopore filter membranes currently utilized to assess RBC "deformability" do not meet the strict metrological requirements of a measuring gauge. They present different kinds of inhomogeneities introducing an useless information (a background noise) into measurement results and expressed as poor reproducibility. Variance reduction can only be achieved by eliminating aberrant results from a series of parallel measurements made with different membranes. To this end a procedure is proposed to identify aberrant values by an iterative statistical regression analysis of data from filter calibration and measurements on RBC suspensions and to express results as "reduced" initial flow rates for a standard filter resistance.

Explore related subjects

ErythrocytesMembranes, ArtificialMicropore FiltersRegression AnalysisRheologyJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

P Teitel, H Malotta, M Leschke, H Schmid-Schönbein. 1984. Recent progress in improving data processing in filtration measurements.. https://doi.org/10.3233/bir-1984-23s140

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2026

Routine transfusion of Rh(D)-positive RBCs to Rh(D)-negative patients designated as do not resuscitate conserves Rh(D)-negative red blood cell inventory.

BACKGROUND: A minority of blood donors are Rh(D)-negative, and Rh(D)-negative red blood cell (RBC) products are often overutilized. As such, Rh(D)-negative RBCs may be difficult to maintain in blood bank inventory. STUDY DESIGN AND METHODS: We changed our blood bank laboratory policy to approve non-alloimmunized Rh(D)-negative patients to receive Rh(D)-positive RBCs for routine transfusion under defined criteria. Those criteria included Rh(D)-negative males (all ages) and females (aged >50 years) who were designated as do not resuscitate (DNR), either with or without intubation, in the electronic medical record. RESULTS: From August 15, 2024 through August 15, 2025, a total of 204 Rh(D)-negative patients met the above criteria and were approved to receive routine Rh(D)-positive RBC transfusions. Within that group, 23 patients received Rh(D)-positive RBCs. The remaining patients either did not require transfusion or were issued Rh(D)-negative RBC units. Since implementing this practice, a total of 68 Rh(D)-negative units were conserved during this time frame. Notably, 28 of the 68 units (41%) were type O, Rh(D)-negative. DISCUSSION: Rh(D)-positive RBCs can be routinely given to non-alloimmunized Rh(D)-negative patients who are not at risk for developing hemolytic disease of the fetus and newborn (HDFN). By creating clear guidelines for the routine administration of Rh(D)-positive RBCs to patients who are not at risk for HDFN, the inventory of Rh(D)-negative RBC units can be directed to those patients who would most benefit from this limited resource.

Erythrocytes↗
PubMed1997

Somatic mutation in paroxysmal nocturnal hemoglobinuria.

The mutation, occurring in a hematopoietic stem cell, creates an erythrocyte clone deficient in proteins capable of blocking complement-mediated lysis. The precise defect lies, however, in the biosynthesis of anchors to tether the proteins. Future research may explain how the clone gains a growth advantage (perhaps shedding light on aplastic anemia). Meanwhile, there remains the challenge of optimal diagnosis and management.

Erythrocytes↗